Bedal International
0841.685.826 · rovalta.com · 25/09/2026
ACTIVE
Bedal International
Financial year 2025 · Closed on 31/12/2025
Net result-3 M €+0,4 %over 1 year
Gross margin-1,3 M €-3,0 %over 1 year
Equity3,5 M €-45,6 %over 1 year
Workforce9,0 ETP+16,9 %over 1 year
Overview
Identity
Source · BCE/KBOBedal International is a Public limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Diepenbeek. It employs on average 9,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0841.685.826
- Incorporation
- 30/11/2011
- Legal form
- Public limited company
- Registered office
- Agoralaan Abis
3590 Diepenbeek · FlandreSee on map - Contributed capital
- 11 151 609,14 €
- Latest accounts
- 31/12/2025
- Average workforce
- 9,0 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods72109Research and experimental development on natural sciences and engineering72190Other research and experimental development on natural sciences and engineering46460Wholesale of pharmaceutical goods46460Wholesale of pharmaceutical goods
Joint committees (2)
- 207
- 2070
Signals
Solid equityGood liquidityHealthy social debts
Financials
Source · NBB, 15 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,3 M € | -3.0% | -1,3 M € | -79.8% | -713,7 k € | -123% | -320,8 k € | +0.0% | -320,9 k € |
| EBITDA | -2,6 M € | -10.4% | -2,4 M € | -72.0% | -1,4 M € | -190% | -473,1 k € | +15.4% | -559 k € |
| Operating result | -2,9 M € | -7.3% | -2,7 M € | -67.5% | -1,6 M € | -129% | -714,3 k € | +3.5% | -740,6 k € |
| Net result | -3 M € | +0.4% | -3 M € | -73.5% | -1,7 M € | -137% | -720,8 k € | +3.9% | -750,1 k € |
| Balance sheet | |||||||||
| Equity | 3,5 M € | -45.6% | 6,5 M € | +1041% | -687,8 k € | -111% | -325,7 k € | -182% | 395,1 k € |
| Total assets | 4,5 M € | -35.1% | 6,9 M € | +124% | 3,1 M € | +61.8% | 1,9 M € | +57.6% | 1,2 M € |
| Cash | 379,4 k € | -48.7% | 739,7 k € | +67.4% | 441,8 k € | -51.8% | 917,3 k € | +108% | 441,1 k € |
| Debts | 945 k € | +106% | 459,1 k € | -87.9% | 3,8 M € | +69.0% | 2,2 M € | +175% | 812,5 k € |
| Other | |||||||||
| Workforce | 9,0 ETP | +16.9% | 7,7 ETP | +54.0% | 5,0 ETP | +150% | 2,0 ETP | -33.3% | 3,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20257 active · 45 ended
Active mandates
Active
Active
Active
Active
Active
Ended mandates
Other companies at this address
Agoralaan Abis 3590 Diepenbeek| Company | CBE no. |
|---|---|
BIOCLUE● Active | 0719.914.105 |
BIOKEY● Active | 0719.913.808 |
BIOSTRAND● Active | 0719.913.907 |
Clinitude● Active | 0478.640.857 |
C-Path● Active | 0762.683.482 |
FOx Biosystems● Bankrupt | 0653.744.366 |
Highstar Engineering● Active | 0685.983.703 |
IDEA FAMILY● Active | 0719.674.177 |
NanoBiotech● Active | 1023.651.490 |
Presscuff● Active | 0800.361.153 |
Reprosci Biosciences● Active | 1008.398.241 |
Sealantium Medical Belgium● Active | 1012.599.727 |
SIMABS● Active | 0732.709.096 |
| 1011.224.604 | |
StingOrg● Active | 0804.587.383 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/07/2026 | 09/07/2025 | 24/07/2024 | 25/08/2023 | 31/07/2022 | 09/08/2021 |
| General meeting | 30/06/2026 | 30/06/2025 | 27/06/2024 | 21/06/2023 | 22/06/2022 | 26/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 13/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/06/2025 | 09/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 27/06/2024 | 24/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 21/06/2023 | 25/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 22/06/2022 | 31/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 26/05/2021 | 09/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 15/05/2020 | 08/10/2020 | Dutch | |
| Abridged model | 31/12/2018 | 21/05/2019 | 31/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 20/06/2018 | 29/06/2018 | Dutch | |
| Abridged modelCorrection | 31/12/2016 | 18/01/2018 | 26/02/2018 | Dutch | |
| Abridged model | 31/12/2016 | 02/05/2017 | 01/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 02/05/2016 | 29/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 18/05/2015 | 30/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 05/05/2014 | 26/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 06/05/2013 | 06/08/2013 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20257 active · 45 ended
Active mandates
Active
Active
Active
Active
Active
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Capital / shares05/02/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates05/12/2025ONTSLAGEN - BENOEMINGEN
- Mandates08/08/2025ONTSLAGEN - BENOEMINGEN
- Mandates19/07/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Other18/03/2024DIVERSEN
- Capital / shares03/07/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates22/05/2023ONTSLAGEN - BENOEMINGEN
- Mandates20/03/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-3 M €↑
- 2024Annual accounts 2024-3 M €↓
- 2023Annual accounts 2023-1,7 M €↓
- 2022Annual accounts 2022-720,8 k €↑
- 2022Name changeBEDAL INTERNATIONAL
- 2021Annual accounts 2021-750,1 k €↓
- 2020Annual accounts 2020-651 k €↓
- 2019Annual accounts 2019-493,8 k €↓
- 2018Annual accounts 2018-440,1 k €↓
- 2017Annual accounts 2017-195,6 k €↓
- 2016Annual accounts 201659,5 k €↑
- 2015Annual accounts 2015-173,6 k €↓
- 2014Annual accounts 2014-124,6 k €↓
- 2013Annual accounts 2013-32,1 k €↓
- 2012Annual accounts 20124,2 k €
- 2012Name changeBedal
- 30/11/2011IncorporationPublic limited company